Fujian Wanchen Biotechnology Group Co., Ltd. (SHE: 300972)
China flag China · Delayed Price · Currency is CNY
79.39
-1.02 (-1.27%)
Jan 2, 2025, 4:00 PM CST

Fujian Wanchen Biotechnology Group Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
2,2931,210115.04216.2133.5427.15
Upgrade
Trading Asset Securities
---20.03--
Upgrade
Cash & Short-Term Investments
2,2931,210115.04236.2433.5427.15
Upgrade
Cash Growth
883.14%951.57%-51.31%604.36%23.52%-59.33%
Upgrade
Accounts Receivable
22.2327.1714.599.572.372.47
Upgrade
Other Receivables
62.88122.874.610.570.30.38
Upgrade
Receivables
85.11150.0519.210.132.672.84
Upgrade
Inventory
1,788733.29100.1155.3750.841.64
Upgrade
Prepaid Expenses
-6.841.48---
Upgrade
Other Current Assets
759.9249.3642.870.646.122.6
Upgrade
Total Current Assets
4,9252,349278.69302.3993.1374.23
Upgrade
Property, Plant & Equipment
1,3171,371796.9506.33506.01523.88
Upgrade
Long-Term Investments
--0.24---
Upgrade
Other Intangible Assets
60.3560.5953.0453.4154.8256.19
Upgrade
Long-Term Accounts Receivable
3.450.730.12---
Upgrade
Long-Term Deferred Tax Assets
94.274.6411.9---
Upgrade
Long-Term Deferred Charges
35.5151.24.9---
Upgrade
Other Long-Term Assets
22.918.0755.351.054.311.33
Upgrade
Total Assets
6,4583,9251,201863.18658.27655.63
Upgrade
Accounts Payable
1,909943.17117.3859.6839.4756.77
Upgrade
Accrued Expenses
102.57108.6227.0613.1812.410.33
Upgrade
Short-Term Debt
821.07510.77148.3764.7888.0668.11
Upgrade
Current Portion of Long-Term Debt
187.979.286.5430.0461.3962.08
Upgrade
Current Portion of Leases
-146.0316.170.08--
Upgrade
Current Income Taxes Payable
148.1654.680.015.61--
Upgrade
Current Unearned Revenue
298.92169.718.931.174.21-
Upgrade
Other Current Liabilities
1,118697.957.0366.929.49
Upgrade
Total Current Liabilities
4,5862,640331.49180.54212.46206.78
Upgrade
Long-Term Debt
244.58148.35110.5-3091.25
Upgrade
Long-Term Leases
306.28324.8131.240.17--
Upgrade
Long-Term Unearned Revenue
37.1840.4543.6229.7715.1612.78
Upgrade
Long-Term Deferred Tax Liabilities
92.5575.7211.93---
Upgrade
Total Liabilities
5,2663,230528.79210.47257.61310.81
Upgrade
Common Stock
179.48154.69153.5153.5115.13115.13
Upgrade
Additional Paid-In Capital
522.85364.09305.15303.67113.44113.44
Upgrade
Retained Earnings
210.64126.58209.5195.54172.09116.25
Upgrade
Total Common Equity
912.98645.36668.15652.71400.65344.82
Upgrade
Minority Interest
279.0250.454.21---
Upgrade
Shareholders' Equity
1,192695.81672.36652.71400.65344.82
Upgrade
Total Liabilities & Equity
6,4583,9251,201863.18658.27655.63
Upgrade
Total Debt
1,5601,139312.8295.07179.44221.44
Upgrade
Net Cash (Debt)
732.970.45-197.78141.18-145.9-194.28
Upgrade
Net Cash Per Share
4.210.46-1.271.00-1.27-1.69
Upgrade
Filing Date Shares Outstanding
179.48172.39153.5153.5115.13115.13
Upgrade
Total Common Shares Outstanding
179.48154.69153.5153.5115.13115.13
Upgrade
Working Capital
339.55-290.99-52.8121.85-119.33-132.55
Upgrade
Book Value Per Share
5.094.174.354.253.483.00
Upgrade
Tangible Book Value
852.63584.77615.11599.3345.84288.63
Upgrade
Tangible Book Value Per Share
4.753.784.013.903.002.51
Upgrade
Buildings
-613.66370.04368.64365.76350.3
Upgrade
Machinery
-698.29446.97433.87418.33387.42
Upgrade
Construction In Progress
-1.24302.8435.053.3610.76
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.